Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
Insulin pricing targeted by FTC
The FTC filed a lawsuit on Friday, alleging three largest pharmacy benefit managers “artificially" inflated the cost of ...
FTC sues OptumRx, rivals over insulin pricing
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
The American Journal of Managed Care43m
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
GoLocalProv54m
FTC Sues Prescription Drug Middlemen Including CVS for Artificially Inflating Insulin Drug Prices
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...
The Washington Post1h
FTC sues pharmacy insurance managers, alleging unfair drug prices
In a statement, the FTC wrote that an executive at a PBM acknowledged this strategy for insulins ... said in a statement. Cigna’s Express Scripts sued the FTC on Tuesday over an interim report issued ...